BHI Weekly News Archives June 30, 2020 412th Edition – June 29, 2020 BioHealth Innovation If you are having trouble viewing this email, please click here June 29,… Super User 0 Love0
BioTalk with Rich Bendis Podcast June 29, 2020 Alex Philippidis, Genetic Engineering and Biotechnology News Senior News Editor, Guests on BioTalk Alex Philippidis joins Rich Bendis on BioTalk to discuss the BioHealth Capital Region from a… Super User 0 Love0
News June 29, 2020 Alex Philippidis, Genetic Engineering and Biotechnology News Senior News Editor, Guests on BioTalk Alex Philippidis joins Rich Bendis on BioTalk to discuss the BioHealth Capital Region from a… Super User 0 Love0
News June 29, 2020 Update on New JLABS Incubator in Washington, DC – Blog Post | JLABS Our newest Johnson & Johnson Innovation JLABS location, JLABS @ Washington, DC, continues to move… Super User 0 Love0
News June 29, 2020 FDA Announces First of Its Kind Pilot Program to Communicate Patient Reported Outcomes from Cancer Clinical Trials | FDA The U.S. Food and Drug Administration today launched Project Patient Voice, an initiative of the… Super User 0 Love0
News June 29, 2020 Scientific Engagement Lead JLABS @ Washington, DC in Washington, District of Columbia | Non Operating Companies Johnson & Johnson Innovation is recruiting a Scientific Engagement Lead of Johnson & Johnson Innovation… Super User 0 Love0
News June 29, 2020 Scott Plank’s newest venture is in the world of organ transplantation – Baltimore Business Journal Scott Plank's latest investment is in a company that aims to solve logistical challenges within… Super User 0 Love0
News June 29, 2020 Novavax charges ahead with $200M, David Mott appointed to board – Washington Business Journal Novavax Inc. plans to advance its Covid-19 vaccine candidate with new additions to the company… Super User 0 Love0
News June 29, 2020 HemoShear Therapeutics Receives FDA Clearance of IND for Phase 2 Study of its Investigational Drug HST5040 for the Treatment of Methylmalonic Acidemia and Propionic Acidemia Charlottesville, Va., June 24, 2020 – HemoShear Therapeutics, a clinical stage company developing treatments for rare metabolic… Super User 0 Love0
News June 29, 2020 Replicate Bioscience and Immunomic Therapeutics Form Collaboration to Combat Infectious Diseases and Cancers | Business Wire ROCKVILLE, Md. & SAN DIEGO--(BUSINESS WIRE)--Replicate Bioscience, Inc. (“Replicate”), a privately-held biopharmaceutical company creating novel… Super User 0 Love0